Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Young Chan Kim

BMBS BMedSci BSc MRes DPhil

Sir Henry Wellcome Fellow, PI, JRF Fellow, Lecturer in Medicine

I earned a BSc degree in Biochemistry from Imperial College London and completed my medical degrees (BMBS, BMedSci and MRes) from the University of Nottingham. I then spent few years working in junior doctor posts before coming to Oxford to start a DPhil in Clinical Medicine. My DPhil studies focused on vaccine development against arthropod-borne viruses supported by Innovate UK funding. I was awarded highly prestigious NDM Graduate Student Prize 2020 (Overall Prize Winner) for my overall performance during my DPhil at the Nuffield Department of Medicine (NDM). Additionally, in 2021, I received an NIHR Oxford BRC grant to support my postdoctoral research and I was elected as a JRF Fellow at Wolfson College. I joined the Oxford Vaccine Group (OVG) as a Senior Postdoctoral Researcher in 2021. 

In 2022, I was awarded the Sir Henry Wellcome Fellowship to start my independent research on development of vaccines and therapeutics against emerging arboviruses. Between 2022 and 2023, I received MRC HIC-VAC and MRC IAA grants to develop serological assays against typhoid and paratyphoid fever, as well as the MLSTF grant to develop a vaccine against Chagas disease. 

Currently, I am a Sir Henry Wellcome Fellow, a Principal Investigator (PI) at the Oxford Vaccine Group (OVG), a JRF Fellow at Wolfson College, a Lecturer in Medicine at Somerville College, and a medical doctor in Internal Medicine at the Oxford University Hospitals NHS Foundation Trust.